NCT06876896 Intra-abdominal Pressure (IAP) During PFA Treatment of A-fib/ A-Flutter
| NCT ID | NCT06876896 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Wake Forest University Health Sciences |
| Condition | Intra-Abdominal Hypertension |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2026-03-03 |
| Primary Completion | 2026-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2026-03-03 with a primary completion date of 2026-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to investigate the intra-abdominal pressure utilizing the Accuryn monitoring system during pulsed field ablation procedures in the electrophysiology lab compared to the type of anesthetic utilized.
Eligibility Criteria
Inclusion Criteria: * Adult patients receiving pulse field ablation procedures for standard of care treatment of atrial fibrillation and/or atrial flutter. * Eligible for Foley catheter placement with no contraindications to Intra-abdominal pressure (IAP) monitoring. Exclusion Criteria: * Patients under the age of 18 will be excluded. * History of intra-abdominal surgery within the past 6 months. * Known contraindications to bladder catheterization or catheter ablation; history of prostate issues / Benign prostatic hyperplasia (BPH) or frequent urinary tract infections * Pregnant or breastfeeding individuals * History of chronic obstructive pulmonary disease (COPD) with home oxygen use
Contact & Investigator
Karuna Rajkumar, MD
PRINCIPAL INVESTIGATOR
Wake Forest University Health Sciences
Frequently Asked Questions
Who can join the NCT06876896 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Intra-Abdominal Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06876896 currently recruiting?
Yes, NCT06876896 is actively recruiting participants. Contact the research team at kputturr@wakehealth.edu for enrollment information.
Where is the NCT06876896 trial being conducted?
This trial is being conducted at Winston-Salem, United States.
Who is sponsoring the NCT06876896 clinical trial?
NCT06876896 is sponsored by Wake Forest University Health Sciences. The principal investigator is Karuna Rajkumar, MD at Wake Forest University Health Sciences. The trial plans to enroll 50 participants.